Roche Launches Updated cobas 6800/8800 Systems with Enhanced Testing Capabilities
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
The elevator and overhead components of Roche's CCM Vertical system are designed to help labs optimize space, productivity, and patient care.
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection.
The Roche test is approved for first-line screening with both SurePath preservative fluid and ThinPrep PreservCyt, the two most common collection media for Pap tests.
Read MoreThe fully automated Cobas 6800 and 8800 systems aim to introduce a new standard for routine molecular testing in the areas of viral load monitoring, donor screening, women’s health, and microbiology.
Read MoreThe new test from Roche expands the menu for healthcare-associated infections testing on the widely adopted Cobas 4800 system.
Read More